A Remarkable Week at JPM 2025
By Iftach Dolev, PhD, CEO and Co-Founder
Last week, QuantalX proudly participated in the J.P. Morgan Healthcare Conference 2025 as part of the prestigious Israeli delegation. This annual gathering is renowned as the largest and most influential healthcare investment symposium, connecting global industry leaders, fast-growing innovators, and members of the investment community.
The Israeli delegation, organized by leading innovation hubs, featured 16 trailblazing companies spanning digital health, medical devices, and biopharma. QuantalX was honored to stand alongside these innovators showcasing groundbreaking advancements. Each company had the opportunity to hold pre-arranged meetings with stakeholders from the National Institutes of Health, corporate partners, family offices, and strategic investors.
Our Experience at JPM 2025
For QuantalX, the conference was not just an event but a milestone. We presented our cutting-edge brain health assessment technology to a global audience eager to learn how it could transform neurodiagnosis decision-making and patient outcomes.
The conversations we had went beyond technology; they delved into the challenges and opportunities shaping the future of healthcare. Thought-provoking questions from C-level executives and strategic partners encouraged us to share our vision of advancing brain health diagnostics through our Delphi-MD platform.
One highlight was the energy in the Startup Showcase, where innovation was met with enthusiasm from investors and peers. Seeing our work resonate within such a vibrant and collaborative environment was truly invigorating.
Key Takeaways from JPM 2025
1. Validation of Our Mission: The overwhelming interest in QuantalX reaffirmed the importance of advancing neurodiagnostics in both clinical and research settings.
2. Partnership Opportunities: The strategic discussions we initiated are paving the way for meaningful collaborations in 2025 and beyond.
3. Global Healthcare Momentum: JPM continues to highlight how interdisciplinary partnerships are key to addressing global healthcare challenges.
A Look Ahead
This dynamic environment left us fully energized to make 2025 a transformative year for QuantalX. The insights, partnerships, and opportunities gained at JPM are already shaping our strategic roadmap.
As we reflect on this exceptional experience, we are inspired by the connections we made and the potential for collaboration with leaders across the healthcare ecosystem. Our commitment to innovation, patient care, and impactful solutions has never been stronger.
Stay Connected
We are deeply grateful to everyone who engaged with us during JPM 2025. Whether you’re an investor, clinician, or industry leader, we welcome the opportunity to connect further and explore how we can work together to lead the global brain health revolution!